ISAC

RESPONSABLE DEL GRUP
Francisco Martín Luján
fmartin.tgn.ics@gencat.cat

Publicacions

Evidence Gaps and Lessons in the Early Detection of Atrial Fibrillation: A Prospective Study in a Primary Care Setting (PREFATE Study).

Clua-Espuny JL, Hernández-Pinilla A, Gentille-Lorente D, Muria-Subirats E, Forcadell-Arenas T, de Diego-Cabanes C, Ribas-Seguí D, Diaz-Vilarasau A, Molins-Rojas C, Palleja-Millan M, Satué-Gracia EM and Martín-Luján F
Aten Primaria.2022 Aug; 54(9):102437.doi:10.3390/biomedicines13010119Epub 2022 Aug 11. Spanish.PMID:39857703

  • Ans: 07/01/2025
  • FI: 3.9
MVP Risk score and new atrial fibrillation diagnosis: Prospective cohort PREFATE study

J. CLUA-ESPUNY, D. GENTILLE-LORENTE, A. HERNÁNDEZ-PINILLA, E. SATUÉ-GRACIA, M. PALLEJÀ-MILLÁN and F. MARTÍN-LUJÁN
Aten Primaria.2022 Aug; 54(9):102437.doi:10.1016/j.aprim.2024.103071Epub 2022 Aug 11. Spanish.PMID:39265318

  • Ans: 01/01/2025
  • FI: 1.8
Evaluation of the psychometric performance of the Spanish and Catalan versions of the patient reported experiences and Outcomes of Safety in Primary Care (PREOS-PC)-Compact questionnaire

M. FIOL-DEROQUE, J. VALDERAS, J. DE LA TORRE, M. SERRANO-RIPOLL, M. GENS-BARBERA, E. SÁNCHEZ-FREIRE, F. MARTÍN-LUJÁN, A. DE LABRY and I. RICCI-CABELLO
Aten Primaria.2022 Aug; 54(9):102437.doi:10.1080/13814788.2023.2296573Epub 2022 Aug 11. Spanish.PMID:38197321

  • Ans: 31/12/2024
  • FI: 2.3
Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway.

Durán CE, Riefolo F, Gini R, Barbieri E, Messina D, Garcia P, Martin M, Villalobos F, Stona L, Carreras JJ, Urchueguía A, Correcher-Martínez E, Zhao J, Lupattelli A, Nordeng H and Sturkenboom M
Aten Primaria.2022 Aug; 54(9):102437.doi:10.1007/s00431-024-05864-1Epub 2022 Aug 11. Spanish.PMID:39535547

  • Ans: 13/11/2024
  • FI: 3
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example.

Bots SH, Belitser S, Groenwold RHH, Durán CE, Riera-Arnau J, Schultze A, Messina D, Segundo E, Douglas I, Carreras JJ, Garcia-Poza P, Gini R, Huerta C, Martín-Pérez M, Martin I, Paoletti O, Bissacco CA, Correcher-Martínez E, Souverein P, Urchuequía A, Villalobos F, Sturkenboom MCJM and Klungel OH
Aten Primaria.2022 Aug; 54(9):102437.doi:10.1093/aje/kwae172Epub 2022 Aug 11. Spanish.PMID:38960670

  • Ans: 04/11/2024
  • FI: 5

Patronat

Col·laboradors

Acreditacions